Jesper Høiland

Mr. Jesper Høiland is a Head-Strategy at Rani Therapeutics Holdings, Inc., an Independent Director at Allarity Therapeutics, Inc., a Chairman at SciBase Holding AB, an Independent Director at ALK-Abello A/S and a Chairman at Allarity Acquisition Corp.
He is on the Board of Directors at Allarity Therapeutics, Inc., ALK-Abello A/S and Flen Health SA. Mr. Høiland was previously employed as a Global Chief Commercial Officer & Senior VP by Ascendis Pharma A/S, an Independent Director by Concert Pharmaceuticals, Inc., a President, Chief Executive Officer& Director by Radius Health, Inc., a President & Executive Vice President by Novo Nordisk North America, Inc., a Senior Vice President-International Operations by Novo Nordisk A/S, a President & Executive Vice President by Novo Nordisk, Inc., a Management Consultant by Liseberg AB, and a General Manager by Novo Nordisk Pharmaceuticals Pty Ltd. He also served on the board at LEO Pharma A/S and Pharmaceutical Research & Manufacturers of America.
He received his undergraduate degree from Copenhagen Business School and a graduate degree from Copenhagen Business School.